GAMMA Investing
TLX icon

GAMMA Investing’s Telix Pharmaceuticals TLX Stock Holding History

GAMMA Investing’s Portfolio TLX Stock Details TLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12.4K Buy
1,128
+850
+306% +$9.6K ﹤0.01% 3225
2026
Q2 		$3.2K Buy
+278
New +$2.83K ﹤0.01% 3629

Other funds holding TLX

Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Aubrey Capital Management
Aubrey Capital Management Edinburgh, United Kingdom $115M AUM 51.42% 1-Year Est. Return
WoodTrust Financial
WoodTrust Financial Wisconsin Rapids, Wisconsin $825M AUM 20.13% 1-Year Est. Return
Aspect Partners
Aspect Partners Fairfax, Virginia $264M AUM 15.76% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Physician Wealth Advisors
Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return
Root Financial Partners
Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

GAMMA Investing's TLX Position: Q3 2026 in Review

GAMMA Investing increased its Telix Pharmaceuticals (TLX) stake by 306% in Q3 2026, buying an estimated $9.6K and bringing the position to 1,128 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3225.

GAMMA Investing first reported a position in TLX in Q2 2026 and has held it in 2 quarters since. 10 funds tracked by Wall St. Rank hold TLX as of Q3 2026.

  • GAMMA Investing held 1,128 shares of Telix Pharmaceuticals worth $12.4K as of Q3 2026.
  • GAMMA Investing bought 850 Telix Pharmaceuticals shares in Q3 2026, an estimated $9.6K.
  • Telix Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3225 holding.
  • GAMMA Investing first reported a position in Telix Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 10 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.